throbber
1' » ‘IILII IHIOIVUM)
`
`CaTI'IeIeer'Va‘inim and can»
`v 53 no THquIy 1‘001)
`(.EeneraI CLHIL‘LTH'H‘:
`\/\/1 (:ACIFS/
`3001i)? ‘IEwifflwNoéj
`
`
`
`' VOLUME 53, NUMBER 3, JULY 2001
`
`Catheterization
`and
`
`Cardiovaspular
`Interventions
`
`CARDIAC ANGIOGRAPHY & INTERVENTIONS
`
` OFFICIAL JOURNAL OF THE SOCIETY FOR
`kiln——
`PROPERTYOFTHENATIONALLIERARYOFMEDICINE
`
`Subject U E. Cc-py'ri 5hr. Laws
`
`Page 1
`
`Medtronic Exhibit 1431
`
`Page 1
`
`Medtronic Exhibit 1431
`
`

`

`All articles published, including but not limited to original research, clinical notes, editorials. reviews. reports. letters, and book reviews, represent the opinions
`and views of the authors and do not reflect any official policy or medical opinion of the institutions with which the authors are affiliated or of the Publisher unless
`this is clearly speCified. Articles published herein are intended to further general scientific research, understanding, and discussion only and are not intended
`and should not be relied upon as recommending or promoting a specific method, diagnosis, or treatment by physicians for any particular patient.
`While the Editor and Publisher believe that drug selections and dosages and the specifications and usage of equipment and devices as set forth herein are in
`accord with current recommendations and practice at the time of publication, they accept no legal responSIbility for any errors or omissions, and make no
`warranty, express or implied, with respect to material contained herein.
`Publication of an advertisement or other discussions of products in the Journal should not be construed as an endorsement of the products or the
`manufacturers' claims. Readers are encouraged to contact the manufacturers With any questions about the features or limitations of the products mentioned.
`
`
`
`rt of this ublication may be reproduced in any form'or'by any means. except as permitted under section
`'
`'
`© 2001 W .
`107 or 1ggyoglsisfiénfigglé”82218623383231;Ngogi/iight ACE, without either the prior written permISSIOt’l of the publisher, or authorization through
`the Copyright Clearance Center, 222 Rosewood Drive, Danvers. MA 01923. (973) 7508400, fax (978) 750-4470. REQUESTS 10 the PUbllSher for P9001530"
`should be addressed to the Permissions Department. Such permission requests and other permission inqumes should be addressed to the Permisswns
`Department. John Wiley 8. Sons, Inc., 605 Third Avenue, New York, NY 10158-0012; (212) 850-6011. fax (212) 850-6008, email: pcrmreq@Wiley.com.
`Catheterization and Cardiovascular Interventions (Print
`ISSN 1522-1946; Online . ISSN 1522-726X at Wiley lnterscience, www.1nterscience.wiley.
`com) is published monthly by Wiley-Liss, lnc., a division of John Wiley 8. Sons, lnc., 605 Third Avenue, New York. NY 10158—0012. Send subscription inquiries
`to: John Wiley & Sons, Inc.. Subscription Department, 9th floor, 605 Third Avenue, New York, NY 10158.
`Advertising inquiries should be addressed to: MJ, Mrvica and Associates. inc., 2 West Taunton Avenue, Berlin, NJ 08009; (609) 760-9360. For advertising
`inquiries outside the United States, contact Caroline Melling, Non-Subscription Sales Manager. John Wiley & Sons, Ltd.. Baffins Lane, Chichester_ West Sussex,
`P019 1 UD, United Kingdom; 44 (0) 1234 770351, fax 44 (O) 1284 770429.
`Subscription price: Volumes 52—54. 2001, twelve issues, $1,760 in the U.S., $1,880 in Canada and Mexico, $1,982 outSIde North America. Special Personal
`Rate: Volumes 52—54, 2001, within North America $295. $367 outside North America. NOTE: Subscriptions at the personal rate MUST be paid by personal
`check, credit card. bank draft or money order. Special “Physicians in Training" Rate: $99 for 2000 Within North America. ALl. orders at the Special Physicians
`in Training rate MUST be accompanied by a Signature certifying participation in the program (Director of Program). All subscriptions outside North America Will
`be sent by air. Payment must be made in US. dollars drawn on a US. bank. Members of the Society for Cardiac Angiography and Interventions receive
`the journal as part of their dues. Offprint sales and inquiries should be directed to the Reprint 3|”an Department, ~10th Wiley 8. 80n8,1nc., 805 Third Avenue,
`New York. NY 10158-0012, (212) 850-8776; all other inquiries should be directed to the Customer SerVice Department (212) 850-6645. Change of Address:
`Please forward to the subscriptions address listed above 6 weeks prior to move; enclose present mailing label With change of address. Claims for undelivered
`copies will be accepted only after the following issue has been received. Please enclose a copy of the mailing label or Cite your subscriber reference number
`in order to expedite handling. Missing copies will be supplied when losses have been sustained in transn and where reserve stock permits. Send claims to John
`Wiley & Sons. Inc., Customer Service. 605 Third Avenue, New York, NY 10158. If claims are not resolved satisfactorily. please write to Caroline Fiothaug,
`Subscription Fulfillment and Sales, John Wiley & Sons, Inc.. 605 Third Avenue, New York, NY 10158.'Cancellations: Subscription cancellations will not be
`accepted after the first issue has been mailed. Periodicals postage paid at N.Y., N.Y.. and at an additional mailing office. POSTMASTER: Send change of
`address to Catheterization and Cardiovascular Interventions. Subscription Systems and Distribution, John Wiley & Sons, lnc., 605 Third Avenue, New York. NY
`10158.
`Indexed by: BIOSIS Data Base . Biomedical Engineering Citation Index - Cardiology Digest - Chemical Abstracts - Current Contents/Clinical Medicine -
`Science citation Index - SCISEARCH Database - Current Opinion in Cardiology - Current Opinion in Radiology 0 Excerpta Medica - Index Medicus. Printed
`in the United States of America.
`Copyright © 2001 Wileeriss, lnc.
`
`This journal is printed on acid-free paper.
`
`Page 2
`
`Medtronic Exhibit 1431
`
`Page 2
`
`Medtronic Exhibit 1431
`
`

`

`Catheterization and Cardiovascular Interventions
`
`
`
`
`July 2001
`
`Volume 53- Number 3
`ORIGINAL STUDIES
`
`Common Femoral Artery Anatomy ls
`Influenced by Demographics and
`Comorbidity: Implications for Cardiac and
`Peripheral Invasive Studies, Guido Schnydel’.
`Neil Sawhney, Brian Whisenant,
`Sotirios Tsimikas, and Zoltan G. Turi ......
`Impact of Abciximab Versus Eptifibatide on
`Length of Hospital Stay for PCI Patients,
`Maureen J. Lage, Beth L. Barber,
`Patrick L. McCollam, Mohan Bala,
`and Joel Scherer ..................
`
`EDITORIAL COMMENT: Glycoprotein IIb/lIla
`Inhibitors: More Different Than Alike?,
`Gregg W. Stone ..................
`
`Percutaneous Coronary Interventions Using a
`New 5 French Guiding Catheter: Results of
`a Prospective Study, Wolfgang A. Schobel,
`'- Spyridopoulos, H.M. Hoffmeister,
`and L. Seipel ....................
`EDITORIAL COMMENT: Bigger Might Not
`Always Be Better, Eulogio Garcia ........
`
`Acute and Long-Term Outcomes of Stenting in
`Coronary Vessel > 3.0 mm, 3.0—2.5 mm,
`and < 2.5 mm, I—Chang Hsieh,
`Chu-Chun Chien, Hern-Jia Chang,
`Ming-Shyan Chem, Kuo-Chun Hung,
`FLin-Chung Lin, and Delon Wu ..........
`Characterization of Ultrasound-Detected
`Cerebral Microemboli in Patients
`Undergoing Cardiac Catheterization Using
`an In Vitro Middle Cerebral Artery Model,
`Yi Yang, Donald G. Grosset, Tao Yang,
`and Kennedy R. Lees ...............
`Significance of Balloon Imprint During
`Coronary Angioplasty, Reuben llia,
`Carlos Cafri, Jean Marc Weinstein,
`Akram Abu-Ful, Miri Merkin,
`Sergei Yaroslavtsev, HareI Gilutz,
`and Azai Appelbaum ................
`
`Thre9-Year Follow-Up After Rotational
`Atherectomy for the Treatment of Diffuse
`In-Stent Restenosis: Predictors of Major
`Adverse Cardiac Events, Peter W. Radke,
`Juergen vom Dahl, Rainer Hoffmann,
`Heinrich G. Klues, Massud Hosseini.
`UWe Janssens, and Peter Hanrath ........
`
`289
`
`296
`
`304
`
`308
`
`313
`
`314
`
`323
`
`331
`
`334
`
`Use of ICHOR-Platelet Works to Assess
`Platelet Function in Patients Treated With
`GP lib/Illa Inhibitors, Nasser M. Lakkis,
`Sima George, Elson Thomas, Mohamad Ali,
`Kirk Guyer, and David Carville ..........
`Noninvasive Detection of Coronary Lesions by
`Multislice Computed Tomography: Results
`of the New Age Pilot Trial,
`Stephen Schroeder, Andreas F. Kopp,
`Andreas Baumbach, Axel Kuettner,
`Christian Herdeg, Albert Rosenberger,
`Hans—K. Selbmann, Claus D. Claussen,
`Martin Oberhotf, and Karl R. Karsch .......
`
`Angiographic Analysis of Immediate and
`Long-Term Results of PTCR vs. PTCA in
`Complex Lesions (COBRA Study),
`Ulrich Dietz, Hans—Juergen Rupprecht,
`Okan Ekinci, Thorsten Dill, Raimund Erbel,
`Karl—Heinz Kuck, Reza Abdollahnia,
`Gerd Rippin, Juergen Meyer,
`and Christian Hamm ................
`
`EDITORIAL COMMENT: Timing and Long-Term
`Benefit, Raoul Bonan ...............
`
`The Puncture Technique: A New Method for
`Transcatheter Closure of Patent Foramen
`Ovale, Carlos E. Ruiz, Ernerio T. Alboliras,
`and Stephen G. Pophal ..............
`Transcatheter Closure of Atrial Septal Defect
`Using Amplatzer Septal Occluder in
`Chinese Adults, Chi-hang Lee, On—hing Kwok,
`Katherine Fan, Elaine Chau, Alex Yip,
`and Wing-hing Chow ...............
`EDITORIAL COMMENT: Transcatheter Closure
`of the Atrial Septum: It’s Been a Long
`Strange Trip, Morton R. Rinder
`and John M. Lasala ................
`
`PRELIMINARY REPORTS
`
`Combined Right Transradial Coronary
`Angiography and Selective Carotid
`Angiography: Safety and Feasibility in
`Unselected Patients, Kwang Soo Cha,
`Moo Hyun Kim, Young Dae Kim,
`and Jong Seong Kim ...............
`
`PEDIATRIC INTERVENTIONS
`
`Morphological Variations of Secundum-Type
`Atrial Septal Defects: Feasibility for
`Percutaneous Closure Using Amplatzer
`Septal Occluders, Tomai Podnar,
`Peter Martanovié, Pavol Gavora,
`and Jozef Masura .................
`
`346
`
`352
`
`359
`
`368
`
`369
`
`373
`
`378
`
`380
`
`386
`
`USe of Fenoldopam to Prevent Radiocontrast
`Nephropathy in High-Risk Patients,
`Hooman Madyoon, Linda Croushore,
`DOuglas Weaver, and Vandana Mathur .....
`This materis I was capiefl
`atthe NLM and may be
`Eubjett. US Copyright Laws
`
`341
`
`Page 3
`
`Medtronic Exhibit 1431
`
`(continued)
`
`Page 3
`
`Medtronic Exhibit 1431
`
`

`

`(continued from previous page)
`Inferior Vena Cava Occlusion Catheter for
`Pediatric Patients With Heart Disease: For
`
`More Detailed Cardiovascular Assessments,
`Hideaki Senzaki, Katuya Miyagawa,
`Yoshikazu Kishigami, Nozomu Sasaki,
`Satoshi Masutani, Mio Taketazu,
`Jun Kobayashi, Toshiki Kobyashi,
`Haruhiko Asano, Shunei Kyo, and Yuji Yokote .
`EDITORIAL COMMENT: lvc Occlusion
`Catheter: Works Well, But Will It Be Widely
`Applied?, Neil Wilson ............... 397
`CASE REPORTS
`
`392
`
`_
`Transcatheter Closure of Large Per5lstent Left
`Superior Vena Cava Causmg Cyan05ls in
`Two Patients Post-Fontan Operation
`
`Utilizing the Gianturco Grifka Vascular
`Occluswn DeVIce, Mlchael R. Recto,
`Franolsco Elbl, and Erle Austin .......... 398
`Amplatzing a 6 Fr Judkins Right Guiding
`Catheter for Increased Success in Complex
`Right Coronary Artery Anatomy,
`Rajpal K. Abhaichand, Thierry Lefévre,
`Yves Louvard, and Marie-Claude Morice .
`Percutaneous Ulnar Artery Approach for
`Coronary Angiography: A Preliminary
`Report in Nine Patients,
`Masayoshi Terashima, Taiichiro Meguro,
`Hisanao Takeda, Norio Endoh, Yuko lto.
`Mikio Mitsuoka, Tatsushi Ohtomo,
`Osamu Murai, Satomi Fujiwara,
`Hidehiko Honda, Yasusuke Miyazaki,
`Ryoji Kuhara, Osamu Kawashima,
`and Shogen Isoyama ...............
`
`405
`
`410
`
`.
`
`.
`
`.
`
`Inadvertent Stent Extraction Six Months After
`Implantation by an Entrapped Cutting
`Balloon, Tareq S. Harb and Frederick S. Ling .
`
`415
`
`BASIC lNVESTlGATlONS
`A Comparison of Four Stent Designs on
`Arterial lniury, Cellular Proliferation,
`Neointima Formation. and Arterial
`Dimensions in an Experimental Porcine
`Model, Allen J. Taylor. Patrlck D. German,
`Bruce Kenwood, Craig Hudak, Gerti Tashko,
`and Renu Virmani
`.
`_
`""""""""
`
`420
`
`EDITORIAL COMMENT: “Metaling” With New
`Stent Designs, Andrew J. Carter,
`David P. Lee, and Alan C. Young ------- 426
`
`lntramyocardial Delivery of FGF2 in
`Combination With Radio Frequency
`Transmyocardial Revascularization,
`Jialin Bao, Wendy Naimark, Maria Palasis,
`ROQBF Laham, Michael Simons,
`and Mark J. Post .................. 429
`
`PRESIDENT’S PAGE
`lntravascular Radiation: Let’s Not Let a
`Promising Therapy Go Unfulfilled,
`Carl L. Tommaso .................. 435
`
`Volume 53, Issue 3 was mailed the week of June 25, 2001.
`
`WILEY-L155
`
`A IOHN WILEY & SONS, INC. , PUBLICATION
`
`New York - Chlchcstcr - Brisbane - Toronto ' Slngaprlru
`
`Thismateriilwaswpiad
`at the NLM a no may be
`Eu eject US Copyright Laws
`
`Thisjournol is online
`l‘DWILEY
`Intersieience
`www.interscience.wileg.com‘
`
`Page 4
`
`Medtronic Exhibit 1431
`
`Page 4
`
`Medtronic Exhibit 1431
`
`

`

`Catheterization and Cardiovascular Interventions 53:308—312 (2001)
`
`Percutaneous Coronary Interventions Using a New 5
`French Guiding Catheter: Results of a Prospective Study
`
`Wolfgang A. Schtibelfk MD, I. Spyridopoulos, MD, H.M. Hoffmeister, MD, and L. Seipel, MD
`The aim of this prospective study was to analyze the technical feasibility, the success rate,
`and the special complications of percutaneous coronary interventions (PCls) using a newly
`released 5 Fr guiding catheter with an inner diameter of 0.058". The study was performed in
`150 consecutive patients subjected to coronary angioplasty. In 89% of the patients, the
`intervention was started with a 5 Fr catheter (J R4 or JL4); in 16 patients a 6 or 7 Fr catheter
`was used because of unstable clinical conditions according to the decision of the interven-
`tional cardiologist. In 12 out of 134 patients, the guiding catheter had to be changed during
`the intervention from 5 Fr to a 6 or 7 Fr catheter due to poor backup support. In 112 out of 118
`patients, the intervention was successfully performed using a 5 Fr catheter (95%); in 12 out
`of 16 patients, after changing the guiding catheter, the overall success rate was 93%. In
`patients with type A and B lesions who were initially treated using a 5 Fr catheter, the
`procedural success rate was 100% (81 out of 81), whereas in patients with type C lesions the
`procedural success rate was 83% (43 out of 53; P = 0.000053, Fisher’s exact test). Further-
`more, in patients with a diameter stenosis < 90%, the procedural success rate was 100% (57
`out of 57), whereas in patients with a diameter stenosis of 90%—100%, the procedural
`success rate was 87% (67 out of 77; P = 0.0050). Stent implantation was performed suc-
`cessfully in 24 patients (18%) using the 5 Fr guiding catheter. This study confirms that PCl
`was technically feasible using a 5 Fr guiding catheter in the majority of consecutive patients
`with a success rate of 95%. There were significant differences in the success rate depending
`on the lesion type and the diameter stenosis. Complications were very rare and were not
`related to the guiding catheter. Limitations of the 5 Fr guiding catheters arose mainly from a
`poor backup support in long lesions and severe stenosis. Cathet Cardiovasc Inten/ent 2001;
`53:308—312.
`0 2001 Wiley-Liss, Inc.
`
`Key words: guiding catheter; 5 French: percutaneous coronary intervention
`
`INTRODUCTION
`
`catheters and the insertion of recently Commercially
`available stents with a diameter of up to 4.0 mm and 21
`length of up to 28 mm. However, no prospective data
`Using 6 Fr guiding catheters for elective percutaneous
`about the technical feasibility of PCI using 5 Fr guiding
`coronary interventions (PCIs) has been shown to be more
`catheters exists. Thus, the aim of this prospective single—
`effective than using larger-diameter catheters. leading to
`user study was to analyze the technical feasibility,
`the
`adecrcase in vascular complications and reduction ofthe
`procedural time as well as the amount of contrast me— success rate, and the special problems of PC] using the
`dium in a prospective, randomized, multicenter trial [1).
`recently available new 5 Fr guiding catheter.
`The area ol‘ the peripheral puncture site is decreased
`'
`' h' (7 2 mmz) in com 'lrison with 6 Fr
`usmg 5 fr she‘“ 5. k-
`,
`.
`p.
`-
`2
`(3.1 mm“) by 31%, in comparison w1th 7 Fr (4.3 mm ) by
`49%, and in comparison with 8 Fr (5.6 mm?) by 61%.
`Using 5 Fr sheaths performing a femoral approach, an
`easier hemostasis at the puncture site could be expected,
`as well as a shorter bed rest in supine position, an earlier
`discharge, and a decreased number of vascular compli- Department of Cardiology, University of Tabingen, Tabingen,
`cations. Prevrously used small guiding catheters (6 Fr Germany
`and smaller) did not allow stent insertion because of an
`inner lumen of less than 0.058" [2_ 6i
`.
`.
`.
`.
`.
`Now a new 5 Fr "tndmg catheter With an inner diam—
`.
`a
`H
`k
`c
`.
`eter of 0.058 (12, Medtronic AVE) 18 on the market.
`This guiding catheter allows thC use of standard balloon
`
`MATERIALS AND METHODS
`Patients
`.
`This study was performed in 150 consecutive patients
`subjected ‘0 PCI primarily by “1‘3 same "“WVGDUOHUI
`
`*Corrcspondencc to: Dr. Wolfgang A. Seliiibcl, Department of Cardi-
`ology, University of Tubingen, Oti‘ricd-Miillcr-Strassc It), 72076 Tii-
`.
`.
`.
`.
`.
`.
`bingcn, Germany. E-mall. wgschoeb@med.uin-ttieblngcn.(le
`
`Received 20 October 2000; Revision accepted 30 January 200i
`
`© 2001 Wiley-Liss, Inc.
`
`Page 5
`
`Medtronic Exhibit 1431
`
`Page 5
`
`Medtronic Exhibit 1431
`
`

`

`Percutaneous Coronary Interventions
`
`309
`
`TABLE 1. Demographic Data of the Patients (n = 150)
`Initially 5 Fr
`Initially 6 or 7 Fr
`(n = I34)
`(n = 16)
`
`11
`%
`n
`”/0
`
`range. 3745
`63 i 10
`Mean age (years : SD)
`59 I 8
`range. 47775
`67
`90
`Male gender
`12
`75
`(it)
`80
`Oneivessel disease
`8
`50
`29
`39
`Twowessel disease
`4
`25
`l
`1
`15
`Three-vessel disease
`4
`25
`(i3
`84
`Stable angina
`5
`31
`28
`38
`Unstable angina
`7
`44
`8
`ll
`Acute myocardial infarction
`3
`19
`1
`l
`Cardiogenic shock
`1
`6
`24
`32
`Prior myocardial infarction
`3
`19
`40
`54
`PCI ad hoc
`4
`25
`Transbrachial approach
`0
`4
`3
`0
`l
`1
`Silus inversus
`
`
`TABLE 11. Baseline Angiographic Characteristics of the Patients (n = 150)
`
`Initially 6 or 7 Fr (n =
`16)
`
`Initially 5 Fr (11 = 134)
`n
`‘70
`n
`%
`
`Target vessel
`Right coronary artery
`Left anterior descending artery
`Left circumflex artery
`Type of lesion
`4
`5
`0
`A
`16
`22
`0
`B]
`40
`54
`19
`3
`132
`40
`53
`81
`13
`C
`range, 707100
`87 : 10
`range. 80-100
`95 I 8
`Mean stenosis ('72: : SD)
`58
`78
`81
`13
`Stenosis 90-100%
`
`
`
`
`3 I9 56Slenosis <90% 42
`
`7
`4
`5
`
`44
`25
`31
`
`44
`69
`21
`
`33
`51
`16
`
`cardiologist at our center between May and August 2000.
`The demographic data of the patients are provided in
`Table I. The data of all patients subjected to PCI were
`collected without any exclusion criteria for this study. All
`patients gave their informed consent to the PCI proce—
`dure.
`
`PCI Procedure
`
`The baseline angiographic characteristics of all pa—
`tients are provided in Table II. The PCI was performed
`according to current clinical practice by the percutaneorrs
`femoral approach in 146 patients (97%) and by pereuta—
`neous transbrachial approach in 4 patients (3%) due to
`clinically significant peripheral vascular disease. All pa—
`tients received either long-term oral therapy with aspirin
`(100 rug/day) or intravenous 250 mg before the proce-
`dure and long—term oral
`therapy. Heparinization was
`performed after arterial access with a bolus of 10,000 U.
`The guiding catheter was inserted through a catheter
`sheath introducer of the same size as the guiding catheter
`to be used during the procedure.
`
`The PCI was intended to be performed by using a nor-
`mal—shaped 5 Fr guiding catheter (Judkin right 4 or left 4).
`In stented patients, adjunctive therapy with oral clopidogrel
`(300 mg) was administered on the day of stent insertion and
`given over a 4—week period (75 mg/day).
`A 6 or 7 Fr guiding catheter was used depending on the
`judgment of the interventional cardiologist about clinical
`condition of the patient,
`the coronary anatomy, and the
`approaching condition of the lesion. Guidewires and bal-
`loon catheters were chosen without restriction by the inter-
`ventional cardiologist. The sheaths were removed either 2
`hr after the PCI or the day after, following the interventioner
`cardiologist’s decision. Local hemostasis after sheath re-
`moval was achieved by manual compression.
`
`Data Analysis
`
`Technical feasibility of the PCI using the 5 Fr guiding
`catheter was judged by the procedural success rate,
`the
`guiding catheter used,
`the need for guiding catheter ex—
`change, rnean number of guiding catheters used, and mean
`number of balloon catheters used. Additional subjective
`
`Page 6
`
`Medtronic Exhibit 1431
`
`Page 6
`
`Medtronic Exhibit 1431
`
`

`

`310
`
`Schébel et al.
`
`evaluation from the interventional cardiologist of the guid-
`ing catheter attributes was noted concerning the backup
`support, the coronary ostia tolerance (unintended deep in—
`tubation, guiding—related dissection, pressure damping),
`ease of balloon or stent movement, and vessel visualization.
`Peripheral vascular conditions such as hematoma or
`false aneurysm were judged by examination from a phy-
`sician other than the primary interventional cardiologist.
`Lesions before and after PCI were classified by visual
`assessment using two orthogonal projections [7]. A re—
`sidual stenosis of < 30% and a normal anterograde flow
`defined angiographic success. All clinical and angio-
`graphic variables,
`including complications, were pro-
`spectively entered into a computerized database file.
`
`Statistical Analysis
`
`The results are expressed as mean value i standard
`deviation (SD). Categorical variables were compared
`with Fisher’s exact test. A P value < 0.05 was consid-
`ered statistically significant.
`
`RESULTS
`
`Overall, 16 of the 150 consecutive patients had to be
`treated with a 6 or 7 Fr guiding catheter. The decision
`was made in patients with poor clinical condition (n =
`11; unstable angina, acute myocardial infarction, or car-
`diogenic shock; see Table I) and in patients in whom the
`angiography has shown that standard 5 Fr catheters were
`not suitable (n = 5).
`Technical results of the 134 patients in whom the PCI
`was started using a 5 Fr guiding catheter are summarized
`in Table III. In 118 out of 134 patients (88%), the PCI
`was performed with 5 Fr guiding catheter. In 16 patients
`(12%), the guiding catheter had to be upgraded to 6 or 7
`Fr due to the coronary anatomy in 3 patients, thejet of a
`mechanical aortic replacement
`in 1 patient. and poor
`backup support
`in 12 patients. The mean number of
`guiding catheters used per patient was 1.1 i 0.4 (range,
`1—3). A change in the balloon catheter was required in 12
`patients. In these patients, the selected balloon catheter
`(3.0—4.0 mm nominal diameter) could not be inserted in
`the target lesion due to severe stenosis and poor backup
`support. Al'ter predilatation using a 1.5 mm balloon cath—
`eter in all patients, the selected balloon catheter could be
`placed in the target lesion. The mean number of balloon
`catheters used per patient was 1.1 i 0.3 (range, 1—2).
`Coronary stenting was performed in 24 (18%) patients
`without any complication. In two patients, an unintended
`deep intubation of the guiding catheter in the coronary
`ostia occurred and was corrected. Vessel visualization
`was reduced by the angioplasty device in the guiding
`catheter, but normalized after the pullback of the device
`halfway out of the guiding catheter.
`
`TABLE III. Technical Results: 134 Patients in Whom Initially a
`5 Fr Guiding Catheter Was Used”
`Initially 5 Fr (11 = 134)
`u
`‘70 or range
`
`Guiding catheter used
`1R4 (5 Fr)
`IL4 (5 Fr)
`1R4 (6 Fr)
`JL4 (6 Fr)
`AU (6 Fr)
`ALZ (6 Fr)
`1R4 (7 Fr)
`Guiding catheter exchange
`Mean number of guiding catheters used
`Guidewires used
`Floppy wirc 0.014”
`Floppy Wire 0014" with distal 0.010"
`Recanalization wire 0.014"
`Balloon catheter used
`Balloon catheter exchange
`Number of balloon catheters used
`Mean balloon diameter (mm)
`Coronary stcnting
`Mean stent diameter (mm)
`Mean stent length (mm)
`Glycoprotein Ilb/IIla receptor blocker
`Fluoroscopic time (min)
`Procedure time (min)
`Amount of contrast dye used (ml)
`
`44
`90
`5
`4
`5
`3
`1
`16
`l L 0.4
`
`I
`
`86
`43
`5
`
`12
`l t 0.3
`1
`3.1 i 0.6
`24
`3 4 1' 0.4
`16.8 r 4.8
`9
`10.1 t 69
`44.8 1 20
`156 i ()1
`
`*JR, Judgkin right; IL, Iudgkin lcl‘t; AL. Amplatz Icl't.
`
`33
`67
`4
`3
`4
`2
`l
`12
`1—3
`
`64
`32
`
`9
`142
`154.0
`18
`3.040
`8724
`7
`24—389
`14—122
`50—370
`
`Overall PCI success rate was 93% in the 134 patients
`initially using 5 Fr guiding catheters (Fig. 1). In 4 out of
`the 16 patients requiring a change to larger guiding
`catheters, the recanalization of a chronic vessel occlusion
`
`could not be achieved. In 6 out of 118 patients treated
`with 5 Fr guiding catheters, the PC] was not successful.
`irrespective of the guiding catheter. In four out of six
`patients, the recanalization 01‘ a chronic vessel closure
`was not achieved; in two out of six patients the passage
`of the target lesion with the gttidewire was not achieved
`due to the vessel anatomy.
`Predictors of procedural failure with the 5 Fr guiding
`catheter were type C lesion morphology (P = 0.000053.
`Fisher’s exact test) and a diameter stenosis of 90% and
`more (P < 0.0050, Fisher’s exact test; Tables IV and V).
`Procedural complications occurred in 3 out of 134 pa-
`tients (2%). One patient was diagnosed with a non—Q-
`wave myocardial infarction following the occlusion of a
`side branch; another patient suffered from a catheter-
`related proximal dissection. requiring stent insertion. In
`one patient, ventricular fibrillation occurred after recan—
`alization and angioplasty of an occluded LAD in acute
`myocardial infarction. There was no need for coronary
`artery bypass grafting and no death occurred.
`Peripheral complications occurred in five patients
`(4%) who had hematoma of diameter 2 2 cm after the
`
`Page 7
`
`Medtronic Exhibit 1431
`
`Page 7
`
`Medtronic Exhibit 1431
`
`

`

`
`
`75%
`
`112
`
`124
`
`I no success
`
` l: procedural
`success
`
`
`
`0
`95 /o
`
`93 %
`
`Percutaneous Coronary Interventions
`
`311
`
`backup support (75%). Procedural failures did not corre—
`late with the size of the guiding catheters, but they were
`in significant relation to the type of the lesion (type C)
`and the severity of the stenosis (90%—100% diameter
`Stenosis). Furthermore, the data demonstrate that about
`80% of all consecutive patients were eligible for PCI
`using a standard 5 Fr guiding catheter, since 16 out of
`150 patients (10.5%) were selected for PCI using 6 or 7
`Fr guiding and in 16 out of 150 patients (10.5%) a change
`in catheter size to 6 or 7 Fr was required. Up to now,
`comparable data about the use of 5 Fr guiding catheters
`have not yet been reported.
`
`Feasibility
`
`Our data demonstrate that the main problem using a 5
`Fr guiding catheter was poor backup support. Particu-
`larly, difficulties in reaching or crossing the target lesion
`with the guidewire in long and severe lesions required an
`exchange of the guiding catheter to 6 or 7 Fr in 12
`patients (9%). Furthermore, difficulties in crossing the
`target lesion with a low-profile balloon catheter required
`a predilatation using a 1.5 mm balloon catheter in 12
`other patients (9%).
`In some other patients,
`the 5 Fr
`guiding catheter could be carefully inserted deeper over
`the guidewire and the balloon catheter shaft in the prox—
`imal vessel
`to improve the backup support. This was
`previously described as the technique of deep seating
`[1,8,9]. Coronary stent insertion was performed without
`any complication after predilatation with a balloon cath-
`eter. Unintended deep intubation of the proximal vessel
`was very rare and easy to correct. One case of obvious
`catheter-induced dissection of the right coronary ostia
`could be successfully treated by stent implantation. Pres-
`sure darnping of the coronary artery occurred in 15% of
`patients treated with 7 or 8 Fr guiding catheters due to
`intubation of the coronary artery [10]. Using 5 Fr guiding
`catheters, pressure damping did not occur in the coronary
`artery, but damping of the recorded pressure was caused
`by the balloon catheter or the stenting device within the
`guiding catheter. Other catheter—related problems did not
`occur, while there was a particularly good kink resis—
`tance, a good torque response, and a good tip visibility.
`The best vessel visualization could be achieved after
`
`retrieval of the balloon catheter otrt of the guiding cath-
`eter. For precise positioning of a stent before deployment
`by adequate angiographic control, a strong injection of
`contrast dye was required, but this is similar for 6 Fr
`guiding catheters with an inner diameter of 0.062” [I].
`Thc mean procedure time of 44.8 i 20 min did not
`differ from studies with patients treated with a 6, 7, or 8
`Fr guiding catheter [1] (41 i 28 min and 36 :22 min,
`respectively). The procedural time was shorter than in an
`older study [10] (about 64 i 35 min). Furthermore, the
`mean iltroroscopy time of our study (10 i 6.9 min) was
`
`initially 5F,
`exchange to SF
`or 7F (n=16)
`
`5F (n=118)
`
`total (n=134)
`
`Fig. 1. Dependence of procedural success on the use of the
`guiding catheter in patients in whom initially a 5 Fr guiding
`catheter was used (n = 134).
`
`TABLE IV. Relation Between Lesion Type and Procedural
`Success in Patients in Whom Initially a 5 Fr Guiding Catheter
`Was Used (n = 134)*
` Type A/B Type C Total
`
`
`No success
`()
`1()
`10
`Procedural success
`81
`43
`124
`
`Total 134 81 53
`
`
`
`*I’ = 0.000053 (Fisher's exact test).
`
`TABLE V. Relation Between Stenosis Rate and Procedural
`Success in Patients in Whom Initially a 5 Fr Guiding Catheter
`Was Used (n = 134)*
`
`Rate of stenosis
` <‘)()% 90-100% Total
`
`
`No success
`0
`10
`10
`Procedural success
`57
`67
`124
`Total
`57
`77
`I 34
`
`*l’ < 0.0050 (Fisher‘s exact test).
`
`in one patient, a false
`removal of the vascular sheath.
`aneurysm occurred and was treated by ultrasound—guided
`manual compression. There was no need for surgical
`interventions or blood transfusions. The mean procedural
`time was 44.8 i 20 min (range, 14—122 min; Table 111)
`and the mean fluoroscopic time was 10.1 i 6.9 min
`(range, 2.4—38 min). The amount of contrast dye used
`was 156 i 61 ml (range, 50—370 ml).
`
`DISCUSSION
`
`Our data demonstrate that PC] was technically feasible
`using a standard 5 Fr guiding catheter in 88% from a total
`of 134 consecutive patients with a success rate 01'95‘70.
`Upgrade in catheter size to 6 or 7 Fr was required in 16
`out of 134 patients (12%) and was mainly related to poor
`
`Page 8
`
`Medtronic Exhibit 1431
`
`Page 8
`
`Medtronic Exhibit 1431
`
`

`

`312
`
`Schébel et al.
`
`very short in comparison to other studies [1,10] (14 i 14
`min,
`I
`l i 9 min, and about 17 i 15 min, respectively).
`The mean amount of contrast dye used in our population
`was comparable to other studies [1,10].
`
`Success Rate
`
`In a study from 1994 comparing 7 Fr and 8 Fr guiding
`catheters in elective PC], the procedural success rate was
`83% [10]. Another study from 1997 comparing 6 Fr with
`7 and 8 Fr guiding catheters in elective PCI reported a
`procedural success rate of 88% in both groups, with a
`comparable stenting rate to our study of about 20% [1].
`At present, the success rate 01‘ PCI is noted at about 75%
`in chronic total occlusions [I 1] and about 98% in acute
`myocardial
`infarction [12]. A recent preliminary study
`about 40 patients reported the same procedural success
`rate 01‘ 95% as our study using 5 Fr guiding catheters [9].
`However, this study did not indicate the selection criteria
`ofthe patients and stents were used in 96% ofthe patients
`[9]. Moreover, patients were selected for elective PC],
`without acute myocardial infarction and chronic vessel
`closure.
`In contrast, our series represents consecutive
`patients. Thus, our data demonstrate that the use of a 5 Fr
`guiding catheter does not decrease the procedural success
`rate of PCI in both elective and unstable patients.
`
`Peripheral Vascular Complications
`
`In our study, no major vascular complications occurred
`and there was no need for surgical
`intervention. Minor
`peripheral vascular complications such as small hematoma
`occurred in 4% of the patients. Only a few data of system-
`atic studies exist concerning peripheral vascular complica-
`tions. In a review of 5,042 PCIs using 6 to l 1 Fr sheaths, no
`correlation was found between sheath size and groin com-
`plications [13];
`in another registry,
`the rate of bleeding
`increased with the size using 6 to 8 Fr and greater sheaths
`[14]. Our experience supports the latter study, namely, that
`a good peripheral vascular result is much easier to achieve
`if a small sheath was used.
`In summary,
`it
`is unclear
`whether there is a definitive advantage of 5 Fr guiding
`catheters over larger guiding catheters concerning periph-
`eral vascular complications.
`This study confirms that PCIs were technically feasi-
`ble using a 5 Fr guiding catheter in the majority of
`consecutive patients with a success rate of 95%. Com-
`plications were very rare and were not related to the
`guiding catheter. Limitations of the 5 Fr guiding cathe-
`
`ters arose mainly from poor backup support
`lesions and severe stenosis.
`
`in long
`
`REFERENCES
`
`EJ
`
`1. Meta D, Meycr P, Touati C, ct al. Comparison of 6F with 7F and
`8F guiding catheters for elective coronary angioplasty: results of
`a

This document is available on Docket Alarm but you must sign up to view it.


Or .

Accessing this document will incur an additional charge of $.

After purchase, you can access this document again without charge.

Accept $ Charge
throbber

Still Working On It

This document is taking longer than usual to download. This can happen if we need to contact the court directly to obtain the document and their servers are running slowly.

Give it another minute or two to complete, and then try the refresh button.

throbber

A few More Minutes ... Still Working

It can take up to 5 minutes for us to download a document if the court servers are running slowly.

Thank you for your continued patience.

This document could not be displayed.

We could not find this document within its docket. Please go back to the docket page and check the link. If that does not work, go back to the docket and refresh it to pull the newest information.

Your account does not support viewing this document.

You need a Paid Account to view this document. Click here to change your account type.

Your account does not support viewing this document.

Set your membership status to view this document.

With a Docket Alarm membership, you'll get a whole lot more, including:

  • Up-to-date information for this case.
  • Email alerts whenever there is an update.
  • Full text search for other cases.
  • Get email alerts whenever a new case matches your search.

Become a Member

One Moment Please

The filing “” is large (MB) and is being downloaded.

Please refresh this page in a few minutes to see if the filing has been downloaded. The filing will also be emailed to you when the download completes.

Your document is on its way!

If you do not receive the document in five minutes, contact support at support@docketalarm.com.

Sealed Document

We are unable to display this document, it may be under a court ordered seal.

If you have proper credentials to access the file, you may proceed directly to the court's system using your government issued username and password.


Access Government Site

We are redirecting you
to a mobile optimized page.





Document Unreadable or Corrupt

Refresh this Document
Go to the Docket

We are unable to display this document.

Refresh this Document
Go to the Docket